The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim

Sang Min Lim

首页> 外文期刊>Pharmaceutical patent analyst >The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim

【24h】

The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim

机译：最近阿尔茨海默病的药物专利景观：对桑敏的采访

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Dr Sang Min Lim is a senior researcher in the Convergence Research Center for Diagnosis, Treatment and Care System of Dementia at Korea Institute of Science and Technology (KIST). He graduated from Seoul National University in Korea, and received his master degree in organic synthesis from the same school. He obtained his PhD degree in medicinal chemistry from Harvard University under the supervision of Professor Nathanael S Gray. He worked as a postdoctoral fellow at California Institute for Biomedical Research (Calibr) under the supervision of Professor Peter G Schultz and Dr Arnab Chatterjee. His current research interest is development of therapeutic agents for a variety of neurodegenerative diseases such as Alzheimer's disease.

机译：桑敏博士是韩国科技学院痴呆症诊断，治疗和护理系统融合研究中心的高级研究员，（KIST）。他毕业于韩国首尔国立大学，并在同一所学校获得了他的有机综合的硕士学位。他在哈佛大学获得了哈佛大学的药物化学博士学位，监督教授的灰色教授。他担任加州生物医学研究所（Calibribribr）的博士后研究所，该研究所在Peter G Schultz教授和Arnab Chatterjee博士的监督下。他目前的研究兴趣是为各种神经变性疾病如Alzheimer疾病的治疗剂的发展。

著录项

来源
《Pharmaceutical patent analyst》 |2019年第6期|共2页
作者
Sang Min Lim;
展开▼
作者单位

Convergence Research Center for Diagnosis Treatment &

Care System of Dementia Korea Institute of;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
aggregation; alzheimer's disease; patent; post-translational modification; tau;

机译：聚集;阿尔茨海默病;专利;翻译后修改;TAU;

相似文献

外文文献
中文文献
专利

1. The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim [J] . Sang Min Lim Pharmaceutical patent analyst . 2019,第6期

机译：最近阿尔茨海默病的药物专利景观：对桑敏的采访
2. Introduction: Advancing Drug Discovery for Alzheimer's Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimer's Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)] [J] . Howard M. Fillit Lorenzo M. Refolo Current Alzheimer Research . 2005,第2期

机译：简介：促进阿尔茨海默氏病的药物发现[ISOA第五届年度研究人员会议，“阿尔茨海默氏病的药物发现和开发的最新进展”，由Elan Pharmaceuticals Inc，The Graphic Expression，Glaxo Smith Kline Pharmaceuticals，Neurochem Inc，Pfizer Inc.赞助（来宾编辑）：霍华德·菲利特和洛伦佐·M·罗菲洛
3. Yun-Young Sunwoo, Sang In Park, Yong-An Chung, Jisoo Lee, Moon-Seo Park, Kyung-Sool Jang, Lee-So Maeng, Dong-Kyu Jang, Ruth Im, Yu Jin Jung, Soon A. Park, Eun-Sun Kang, Min-Wook Kim, Young-Min Han [J] . Evidence-based complementary and alternative medicine: eCAM . 2012,第10期

机译：孙润荣，朴尚恩，钟永安，李智秀，文雪朴，张庆S，李素缅，张东圭，露丝·林，于进政，不久A.朴恩-孙康，金敏旭，韩永敏
4. Landscape Design and Neuroscience Cooperation: Contributions to the Non-pharmacological Treatment of Alzheimer's Disease [C] . Rachel Zuanon, Barbara Alves Cardoso de Faria International conference on human-computer interaction;International conference on digital human modeling . 2018

机译：景观设计与神经科学合作：对阿尔茨海默氏病非药物治疗的贡献
5. Patent policy and entry: Evidence from pharmaceutical patent challenges [D] . Mulcahy, Andrew 2011

机译：专利政策和准入：来自制药专利挑战的证据
6. Patent landscape of neglected tropical diseases: an analysis of worldwide patent families [O] . Folahanmi Tomiwa Akinsolu, Vitor Nobre de Paiva, Samuel Santos Souza, 2017

机译：被忽视的热带病的专利格局：全球专利家族分析
7. Technological Foresight Based on Citing and Cited Patents of Cellulose with Pharmaceutical Aplications. Technological Foresight Based on Citing and Cited Patents of Cellulose with Pharmaceutical Aplications. Technological Foresight Based on Citing and Cited Patents of Cellulose with Pharmaceutical Aplications. [O] . Deysimar de Souza Carvalho, Leandra Guimarães de Oliveira, Eduardo Winter, 2009

机译：基于纤维素的引用和引用专利的技术远见，具有药物应用。基于纤维素的引用和引用专利的技术远见，具有药物应用。基于纤维素的引用和引用专利的技术远见，具有药物应用。
8. Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias.Clinical Practice Guideline Number 19; Early Identification of Alzheimer's Disease and Related Dementias. Quick Reference Guide for Clinicians Number 19; Early Alzheimer's Dis [R] . Costa, P. T., Williams, T. F., Albert, M. S., 1996

机译：阿尔茨海默病和相关痴呆的认可和初步评估。临床实践指南第19号;阿尔茨海默病及相关痴呆的早期鉴定。临床医生快速参考指南第19号;早期阿尔茨海默氏症

The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim

摘要

著录项

相似文献

相关主题

期刊订阅